Cardiology

ACCORD trial suggests lowering blood-pressure to a target of <120 mm Hg systolic.

In this week's Homerun Slides, the action and safety of the type 2 medication, bromocriptine.

In this week's Homerun Slides, the natural history of type 2 diabetes and factors contributing to CV risk.

To wrap up this series, we present the final two installments of the conversation between Diabetes in Control Publisher Steve Freed and Dr. Richard Bergman. In part 5, Steve learns more about the institute founded and led by Dr. Bergman at Cedars-Sinai. In part 6, Steve asks what is more important — blood pressure or blood glucose levels?

In this week's Homerun Slides, the vicious circle of hyperinsulinemia in patients with type 2 diabetes.

In this week's Homerun Slides, we begin a new series on the role of anti-diabetes medications in reducing cardiovascular risk and outcomes in diabetes patients.

Evidence shows cardio-protective ability beyond glucose-lowering mechanism of action.

FACT: Up to two-thirds of eligible Hispanics are not taking statins.

Patients with highest fasting insulin had almost threefold higher risk of hypertension, left ventricular hypertrophy.

Appropriate intensification and deintensification in medication use may be of benefit.